Phillyrin alleviates high glucose-induced oxidative stress and inflammation in HBZY-1 cells through inhibition of the PI3K/Akt signaling pathway.
Chunjing YangLi BaoZhengyuan ShiXiqiao XvDechun JiangLongtai YouPublished in: The Journal of pharmacy and pharmacology (2024)
All results showed that phillyrin might be a promising therapeutic agent for the treatment of DN.